Exclusive extracts from this 69-page-long report:
- Who are the key players?
The medical technology (medtech) industry, estimated to be worth around €335 billion in 2015, is highly fragmented. The market is split between a handful of large, deep-pocketed companies, such as Johnson & Johnson and GE Healthcare, and a myriad of small-scale, specialised players. For example, 95% of the total number of medtech firms in Europe are SMEs. [...]
Groups analysed in this report include: Medtronic, Philips , Johnson & Johnson Medical Devices, Abbott Laboratories, GE Healthcare , Siemens, Becton Dickinson , Roche Diagnostics, Stryker and Boston Scientific Corporation.
- What are the players' strategies?
As a trendsetter in the industrial internet, GE Healthcare is leveraging its Predix cloud-enabled platform to provide analytics and applications that transform big data from connected medical devices into business intelligence. At a time when increased emphasis is being placed on value-based healthcare services, GE is looking to combine its medical expertise with consulting know-how in order to build “game-changing” collaborations. For example, GE will deliver software solutions, such as the Carestation Insights apps for improved capacity utilisation in the emergency room, and, in partnership with Accenture, solutions for faster medical claims management. […]
- What are the players' key growth and profitability drivers?
Following the closing of the €40bn Covidien acquisition, Medtronic's 2016 performance was boosted across all geographies and segments, despite negative currency translation effects costing €1.2bn, related to the strengthening of the US Dollar. In the US, its largest market, growth was particularly strong in the Cardiac and Vascular business unit. [...]